Diebold Nixdorf, Incorporated
DBD
$71.66
-$3.72-4.94%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.87B | 3.86B | 3.81B | 3.69B | 3.67B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.87B | 3.86B | 3.81B | 3.69B | 3.67B |
| Cost of Revenue | 2.85B | 2.84B | 2.80B | 2.75B | 2.74B |
| Gross Profit | 1.02B | 1.02B | 1.00B | 940.20M | 934.10M |
| SG&A Expenses | 585.20M | 585.30M | 585.00M | 593.50M | 589.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 400.00K | 1.10M | -1.70M | -1.20M | 200.00K |
| Total Operating Expenses | 3.52B | 3.51B | 3.47B | 3.43B | 3.42B |
| Operating Income | 347.90M | 343.40M | 336.30M | 262.70M | 256.60M |
| Income Before Tax | 160.30M | 142.40M | 121.50M | 71.00M | 27.90M |
| Income Tax Expenses | 46.40M | 32.00M | 24.10M | 17.70M | 38.00M |
| Earnings from Continuing Operations | 113.90 | 110.40 | 97.40 | 53.30 | -10.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.70M | -2.50M | -2.80M | -2.70M | -2.80M |
| Net Income | 111.20M | 107.90M | 94.60M | 50.60M | -12.90M |
| EBIT | 347.90M | 343.40M | 336.30M | 262.70M | 256.60M |
| EBITDA | 461.20M | 457.10M | 452.50M | 394.20M | 387.00M |
| EPS Basic | 3.10 | 2.98 | 2.62 | 1.38 | -0.34 |
| Normalized Basic EPS | 4.53 | 4.10 | 3.64 | 2.29 | 1.90 |
| EPS Diluted | 3.05 | 2.94 | 2.58 | 1.37 | -0.34 |
| Normalized Diluted EPS | 4.45 | 4.05 | 3.59 | 2.27 | 1.89 |
| Average Basic Shares Outstanding | 141.80M | 144.60M | 147.10M | 148.90M | 150.00M |
| Average Diluted Shares Outstanding | 144.30M | 146.50M | 148.40M | 149.70M | 150.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |